Evaluating Quality of Care Indicators for Metastasis Development in Cutaneous Squamous Cell Carcinoma Among Mexican Renal Transplant Recipients

Andrea Malagon-Liceaga, Jesus Alejandro Romero-Aguila, Bonfilio Roberto Lazcano-Prieto, Fanny Carolina Lopez-Jimenez, Rebeca Palafox-Romo, Samantha Paola Bermudez Rodriguez, Verónica Monserrat Díaz Sanchez, Judith Dominguez-Cherit, Silvia Mendez-Flores, Ana Lilia Ruelas-Villavicencio
{"title":"Evaluating Quality of Care Indicators for Metastasis Development in Cutaneous Squamous Cell Carcinoma Among Mexican Renal Transplant Recipients","authors":"Andrea Malagon-Liceaga,&nbsp;Jesus Alejandro Romero-Aguila,&nbsp;Bonfilio Roberto Lazcano-Prieto,&nbsp;Fanny Carolina Lopez-Jimenez,&nbsp;Rebeca Palafox-Romo,&nbsp;Samantha Paola Bermudez Rodriguez,&nbsp;Verónica Monserrat Díaz Sanchez,&nbsp;Judith Dominguez-Cherit,&nbsp;Silvia Mendez-Flores,&nbsp;Ana Lilia Ruelas-Villavicencio","doi":"10.1002/jvc2.70030","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Cutaneous squamous cell carcinoma (cSCC) poses a high metastatic risk in immunosuppressed individuals, especially organ transplant recipients (OTRs). Despite international guidelines recognizing these risks, no universal standard exists for assessing quality of care (QoC) in cSCC. QoC indicators, as defined by NICE, ensure evidence-based management, including histopathology, treatment timelines, and follow-up, yet adherence remains challenging, particularly in low- and middle-income countries.</p>\n </section>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>To evaluate the occurrence of metastasis in cSCC among Mexican renal transplant recipients (RTRs) and assess how QoC indicators influenced this outcome.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Analysis of a subgroup of patients with invasive cSCC from a cohort of 1642 RTRs, excluding keratoacanthomas, SCC in situ, and externally treated tumors, leaving 123 cases. QoC indicators included pathology report completeness, diagnosis-to-surgery time, follow-up duration, and surgical team involvement. Comprehensive reports documented tumor size, depth, differentiation, and perivascular/perineural invasion. Statistical analysis included Fisher's exact test, Wilcoxon-Mann-Whitney test, and LASSO logistic regression.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among the 123 tumors, 4.9% metastasized, 83.3% in men. Notably, 19.4% of tumors had a comprehensive pathology report. The AJCC 7 guidelines in 2015 improved reporting quality, with 30.5% of reports meeting comprehensive criteria post-2015, compared to 9.4% before (<i>p</i> = 0.005). LASSO logistic regression identified predictors of metastasis: tumor differentiation (OR 3.0, 95%CI: 2–4.5), reporting tumor depth (OR 1.4, 95%CI: 1.2–1.7), and reporting perivascular invasion (OR 8.66, 95%CI: 4.8–15.6). This suggests that pathologists may have been more likely to document aggressive-looking tumors. Time to surgery was similar across cases, but multidisciplinary teams were more involved in metastatic cases.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The lack of universally recognized QoC guidelines for cSCC treatment in OTRs presents a significant gap in patient care. Standardized reporting and treatment protocols, similar to melanoma guidelines, could improve outcomes and support research like ours. The study's retrospective nature and missing data require cautious interpretation.</p>\n </section>\n </div>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 2","pages":"499-502"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70030","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JEADV clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.70030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Cutaneous squamous cell carcinoma (cSCC) poses a high metastatic risk in immunosuppressed individuals, especially organ transplant recipients (OTRs). Despite international guidelines recognizing these risks, no universal standard exists for assessing quality of care (QoC) in cSCC. QoC indicators, as defined by NICE, ensure evidence-based management, including histopathology, treatment timelines, and follow-up, yet adherence remains challenging, particularly in low- and middle-income countries.

Objectives

To evaluate the occurrence of metastasis in cSCC among Mexican renal transplant recipients (RTRs) and assess how QoC indicators influenced this outcome.

Methods

Analysis of a subgroup of patients with invasive cSCC from a cohort of 1642 RTRs, excluding keratoacanthomas, SCC in situ, and externally treated tumors, leaving 123 cases. QoC indicators included pathology report completeness, diagnosis-to-surgery time, follow-up duration, and surgical team involvement. Comprehensive reports documented tumor size, depth, differentiation, and perivascular/perineural invasion. Statistical analysis included Fisher's exact test, Wilcoxon-Mann-Whitney test, and LASSO logistic regression.

Results

Among the 123 tumors, 4.9% metastasized, 83.3% in men. Notably, 19.4% of tumors had a comprehensive pathology report. The AJCC 7 guidelines in 2015 improved reporting quality, with 30.5% of reports meeting comprehensive criteria post-2015, compared to 9.4% before (p = 0.005). LASSO logistic regression identified predictors of metastasis: tumor differentiation (OR 3.0, 95%CI: 2–4.5), reporting tumor depth (OR 1.4, 95%CI: 1.2–1.7), and reporting perivascular invasion (OR 8.66, 95%CI: 4.8–15.6). This suggests that pathologists may have been more likely to document aggressive-looking tumors. Time to surgery was similar across cases, but multidisciplinary teams were more involved in metastatic cases.

Conclusions

The lack of universally recognized QoC guidelines for cSCC treatment in OTRs presents a significant gap in patient care. Standardized reporting and treatment protocols, similar to melanoma guidelines, could improve outcomes and support research like ours. The study's retrospective nature and missing data require cautious interpretation.

评价墨西哥肾移植受者皮肤鳞状细胞癌转移发展的护理指标质量
背景:皮肤鳞状细胞癌(cSCC)在免疫抑制个体中具有很高的转移风险,尤其是器官移植受体(OTRs)。尽管国际指南承认这些风险,但目前尚无评估cSCC护理质量(QoC)的通用标准。NICE定义的QoC指标确保了基于证据的管理,包括组织病理学、治疗时间表和随访,但依从性仍然具有挑战性,特别是在低收入和中等收入国家。目的评估墨西哥肾移植受者(RTRs)中cSCC转移的发生情况,并评估QoC指标如何影响这一结果。方法对1642例RTRs队列中浸润性cSCC患者进行亚组分析,排除角膜棘层瘤、原位SCC和外部治疗肿瘤,留下123例。QoC指标包括病理报告完整性、诊断至手术时间、随访时间和手术团队参与情况。全面的报告记录了肿瘤的大小、深度、分化和血管周围/神经周围的侵犯。统计分析采用Fisher精确检验、Wilcoxon-Mann-Whitney检验和LASSO logistic回归。结果123例肿瘤转移率4.9%,男性83.3%。值得注意的是,19.4%的肿瘤有全面的病理报告。2015年的AJCC 7指南提高了报告质量,2015年后有30.5%的报告符合综合标准,而之前为9.4% (p = 0.005)。LASSO logistic回归确定了转移的预测因素:肿瘤分化(OR 3.0, 95%CI: 2-4.5),报告肿瘤深度(OR 1.4, 95%CI: 1.2-1.7),报告血管周围侵犯(OR 8.66, 95%CI: 4.8-15.6)。这表明病理学家可能更有可能记录看起来具有侵袭性的肿瘤。不同病例的手术时间相似,但多学科团队更多地参与转移性病例。结论缺乏公认的OTRs cSCC治疗QoC指南,在患者护理方面存在重大差距。标准化的报告和治疗方案,类似于黑色素瘤指南,可以改善结果,支持像我们这样的研究。该研究的回顾性和缺失的数据需要谨慎的解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信